Atlas Trials

Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu

Clinical trial NCT04279197 · COMPLETED

Trial details

NCT number
NCT04279197
Sponsor
ShuGuang Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Fibrosis Due to COVID-19
Start date
2020-04-23
Primary completion
2021-03-24
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.